3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
3
Vaginitis
1
Urologic Neoplasms
1
Urologic Diseases
1
Sexuality
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Hypogonadism
1
Dyspareunia
1
Castration-Resistant Prostate Carcinoma
1
Interventions
exemestane
1
Testosterone Propionate
1
Phenylephrine
1
Leuprolide
1
Letrozole
1
Holistic Health
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Exercise Movement Techniques
1
Cognitive Behavioral Therapy
1
Bupropion
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sexual Dysfunctions, Psychological
×
Testosterone Propionate
×
Clear all
NCT00612742
2021-10-29
BLOOM
BioSante Pharmaceuticals
Phase 3
Completed
3,656 enrolled